Insignia
Payments companies reported to CMS as associated with Insignia. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Insignia, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Insignia
These are the largest totals companies reported as associated with Insignia. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jeremy Gililland | Salt Lake City, UT | Orthopaedic Surgery | $750,438.76 |
| Robert Molloy | Cleveland, OH | Orthopaedic Surgery | $736,510.98 |
| Cory Calendine | Franklin, TN | Adult Reconstructive Orthopaedic Surgery | $652,392.71 |
| Austin Matthews | Lumberton, NC | Foot & Ankle Surgery | $278,393.19 |
| Matthew Austin | New York, NY | Adult Reconstructive Orthopaedic Surgery | $272,000.56 |
| David Mayman | New York, NY | Orthopaedic Surgery | $233,530.88 |
| Nicholas Colacchio | Falmouth, ME | Orthopaedic Surgery | $95,654.06 |
| Steven Harwin | New York, NY | Orthopaedic Surgery | $94,000.00 |
| James Crutcher | Seattle, WA | Orthopaedic Surgery | $86,779.05 |
| Joseph Nessler | Sartell, MN | Orthopaedic Surgery | $82,140.17 |
Prescribed Insignia?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.